嶺東科技大學 |

Impact of TRIPS in India : an access to medicines perspective

[NT 42944] Record Type:	[NT 8598] Electronic resources : [NT 40817] monographic
[NT 47348] Title Information:	an access to medicines perspective
[NT 47261] Author:	MalhotraPrabodh, 1951-
[NT 47356] Secondary Intellectual Responsibility:	Palgrave Connect (Online service)
[NT 47351] Place of Publication:	Basingstoke, Hampshire New York
[NT 47263] Published:	Palgrave Macmillan;
[NT 47352] Year of Publication:	2010
[NT 47264] Description:	1 online resource (xxi, 320 p.)ill. :
[NT 47266] Subject:	Pharmaceutical industry - India. -
[NT 47266] Subject:	Pharmaceutical policy - India. -
[NT 47266] Subject:	Health services accessibility - India. -
[NT 47266] Subject:	Drug Industry - India. -
[NT 47266] Subject:	Health Services Accessibility - India. -
[NT 47266] Subject:	International Cooperation - India. -
[NT 47266] Subject:	Patents as Topic - legislation & jurisprudence - India. -
[NT 47266] Subject:	(1994) -
[NT 47266] Subject:	Agreement on Trade-Related Aspects of Intellectual Property Rights. -
[NT 47266] Subject:	Health services accessibility. -
[NT 47266] Subject:	India. -
[NT 47266] Subject:	Pharmaceutical industry. -
[NT 47266] Subject:	Pharmaceutical policy. -
[NT 47266] Subject:	BUSINESS & ECONOMICS - Industries -
[NT 51458] Online resource:	http://www.palgraveconnect.com/doifinder/10.1057/9780230290747An electronic book accessible through the World Wide Web; click for information
[NT 47265] Notes:	Description based on print version record.
[NT 51398] Summary:	Over the last three decades, drug prices in India have declined from one of the highest to one of the lowest in the world. Yet, under the current healthcare model, only around 35 per cent of people in India have access to medicines. In the lead up to 2005, when TRIPS compliant regime was introduced in India, there were apprehensions about the drug prices rising under the new regime, which would further restrict access to medicine. This book examines the impact of TRIPS on drug prices and exports of drugs and pharmaceuticals in India. It goes on to develop a new healthcare model, which if implemented, would extend access to medicines to India's entire population. Sensitivity tests show that the proposed model is affordable, equitable and implementable, and can be replicated in other developing countries. This book is indispensable reading for all interested in development economics, intellectual property rights in developing countries, pharmaceutical markets and health systems.
[NT 50961] ISBN:	9780230290747electronic bk.
[NT 50961] ISBN:	0230290744electronic bk.
[NT 60779] Content Note:	Foreword Acknowledgments Introduction PART I: INFLUENCE OF GLOBAL FORCES ON ACCESS TO MEDICINES The World Trade Organization and the TRIPS Agreement The Global Pharmaceutical Industry and Developing New Drugs PART II: ACCESS TO MEDICINES IN INDIA Development of India's Pharmaceutical Industry TRIPS and the Indian Patents Regime Price Controls and Drug Affordability in India: Policy Options Health Insurance in India Broadening the Access to Medicines and Healthcare in India PART III: GLOBAL PERSPECTIVE Is TRIPS Appropriate for Developing Countries? Which Way Ahead? Final Conclusions References.

Impact of TRIPS in India : an access to medicines perspective
Malhotra, Prabodh

Impact of TRIPS in India : an access to medicines perspective / Prabodh Malhotra. - Basingstoke, Hampshire New York : Palgrave Macmillan, 2010. - 1 online resource (xxi, 320 p.) ; ill..
Foreword.
Description based on print version record..
Includes bibliographical references and index..
ISBN 9780230290747ISBN 0230290744
Pharmaceutical industryPharmaceutical policyHealth services accessibilityDrug IndustryHealth Services AccessibilityInternational CooperationPatents as Topic(1994)Agreement on Trade-Related Aspects of Intellectual Property Rights.Health services accessibility.India.Pharmaceutical industry.Pharmaceutical policy.BUSINESS & ECONOMICS -- legislation & jurisprudence -- Industries -- India. -- India. -- India. -- India. -- India. -- India. -- India.

Impact of TRIPS in India : an access to medicines perspective
LDR:02679clm 2200313 4500 001 280356
005 20130621114658.0
009 ocn696332299
010 1 $a 9780230290747 $b electronic bk.
010 1 $a 0230290744 $b electronic bk.
010 1 $z 9780230272781
010 1 $z 0230272789
012 0 $a 9786612997815
100 $a 20140528
101 0 $a eng
102 $a gb
135 $a v
200 1 $a Impact of TRIPS in India $e an access to medicines perspective $f Prabodh Malhotra.
204 1 $a electronic resource
210 $a Basingstoke, Hampshire New York $d 2010 $c Palgrave Macmillan
215 1 $a 1 online resource (xxi, 320 p.) $c ill.
300 $a Description based on print version record.
320 $a Includes bibliographical references and index.
327 1 $a Foreword $a Acknowledgments $a Introduction $a PART I: INFLUENCE OF GLOBAL FORCES ON ACCESS TO MEDICINES $a The World Trade Organization and the TRIPS Agreement $a The Global Pharmaceutical Industry and Developing New Drugs $a PART II: ACCESS TO MEDICINES IN INDIA $a Development of India's Pharmaceutical Industry $a TRIPS and the Indian Patents Regime $a Price Controls and Drug Affordability in India: Policy Options $a Health Insurance in India $a Broadening the Access to Medicines and Healthcare in India $a PART III: GLOBAL PERSPECTIVE $a Is TRIPS Appropriate for Developing Countries? $a Which Way Ahead? $a Final Conclusions $a References.
330 $a Over the last three decades, drug prices in India have declined from one of the highest to one of the lowest in the world. Yet, under the current healthcare model, only around 35 per cent of people in India have access to medicines. In the lead up to 2005, when TRIPS compliant regime was introduced in India, there were apprehensions about the drug prices rising under the new regime, which would further restrict access to medicine. This book examines the impact of TRIPS on drug prices and exports of drugs and pharmaceuticals in India. It goes on to develop a new healthcare model, which if implemented, would extend access to medicines to India's entire population. Sensitivity tests show that the proposed model is affordable, equitable and implementable, and can be replicated in other developing countries. This book is indispensable reading for all interested in development economics, intellectual property rights in developing countries, pharmaceutical markets and health systems.
605 $a Agreement on Trade-Related Aspects of Intellectual Property Rights $3 303365
606 $a Pharmaceutical industry $y India. $2 lc $3 300805
606 $a Pharmaceutical policy $y India. $3 303366
606 $a Health services accessibility $y India. $3 303367
606 $a Drug Industry $y India. $3 303368
606 $a Health Services Accessibility $y India. $3 303369
606 $a International Cooperation $y India. $3 303370
606 $a Patents as Topic $x legislation & jurisprudence $y India. $3 303371
606 $a (1994) $3 303372
606 $a Agreement on Trade-Related Aspects of Intellectual Property Rights. $3 303373
606 $a Health services accessibility. $3 303374
606 $a India. $3 260575
606 $a Pharmaceutical industry. $3 303375
606 $a Pharmaceutical policy. $2 lc $3 276054
606 $a BUSINESS & ECONOMICS $x Industries $x Pharmaceutical & Biotechnology. $2 bisacsh $3 303376
676 $v 22 $a 338.4/761510954
680 $a HD9672.I52 $b M35 2010
686 $a 2010 M-470 $a QV 736
700 1 $a Malhotra $b Prabodh $f 1951- $3 303364
712 0 2 $a Palgrave Connect (Online service) $3 302425
801 0 $a tw $b ltu
856 4 0 $3 Palgrave Connect $u http://www.palgraveconnect.com/doifinder/10.1057/9780230290747 $z An electronic book accessible through the World Wide Web; click for information